FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033147043> ?p ?o ?g. }

• W3033147043 abstract "ÖZET Amaç: İnfantil hemanjiomlar (İH) endotel hücrelerinin benign proliferasyonlarıdır. Çocukluk çağının en sık görülen benign tümörleridir. İH’ın çoğu kendiliğinden gerilerken, yaklaşık %10'u medikal tedavi gerektirir. İH’ın medikal tedavisinde kortikosteroidler, interferon ve vinkristin eskiden beri kullanılan ajanlardır. Son yıllarda topikal beta-blokörler teröpatik etkinliklerinin gösterilmesi ve sistemik yan etkilerin daha az görülmesi nedeniyle IH tedavisinde alternatif bir tedavi yöntemi olarak kullanılmaya başlanmıştır. Bu çalışmada, topikal beta-bloker kullanılan yüzeyel İH hastalarının epidemiyolojik özellikleri ve tedavi etkinliğinin değerlendirilmesi amaçlanmıştır. Gereç ve yöntem: Erzurum Bölge Eğitim ve Araştırma Hastanesi Çocuk Hematoloji-Onkoloji polikliniğine Nisan 2015 ile Mayıs 2017 tarihleri arasında başvuran, yaşları 0-36 ay arasında olan 30 hasta çalışmaya dahil edildi. Yüzeyel hemanjiyomu olan hastalara lezyon bölgesine %0,5 timolol maleate solüsyon, sabah ve akşam ikişer damla olacak şekilde uygulandı. Bulgular: Tedavi öncesi hemanjiomların çapı ortalama 2,5 ± 1,5 cm iken, tedavi sonrası 1,3 ± 0,8 cm olarak belirlendi (p<0,0001). Sonuç: Lezyonda belirgin gerilemeye yol açması nedeni ile timolol kullanımı ümit vadetmektedir. Ancak daha geniş çaplı ve kontrollü-randomize çalışmalara ihtiyaç olduğu da bir gerçektir. ABSTRACT Aim: Infantile hemangiomas are benign proliferation of endothelial cells. It is the most common benign tumor of childhood. Most of the IH is spontaneously regressing, and about 10% requires medical treatment. Corticosteroids, interferon and vincristine have long been used in medical treatment of IH. In recent years, topical beta-blockers have been used as an alternative treatment modality for the treatment of IH because of their therapeutic efficacy and low systemic side effects. The aim of this study was to evaluate the epidemiological features and treatment efficacy of superficial IH patients using topical beta-blockers. Materials and Methods: For this purpose, 30 patients, aged between 0-36 months, who applied to the Pediatric Hematology-Oncology Polyclinic of the Erzurum Regional Education and Research Hospital between April 2015 and May 2017 were included in the study. In patients with superficial hemangioma, 0,5 % timolol maleate solution was applied to the lesion area, two drops in the morning and in the evening. Results: The mean diameter of the hemangiomas before treatment was 2.5 ± 1.5 cm and 1.3 ± 0.8 cm after the treatment. (P<0,0001). Conclusıons: The use of timolol is promising because it causes a marked regression in the lesion. However, it is a fact that wider-scale and controlled-randomized studies are needed. Key words: hemangioma, treatment" @default.
• W3033147043 created "2020-06-12" @default.
• W3033147043 creator A5003503947 @default.
• W3033147043 creator A5009567221 @default.
• W3033147043 creator A5083712446 @default.
• W3033147043 creator A5086622209 @default.
• W3033147043 creator A5086849686 @default.
• W3033147043 date "2020-09-01" @default.
• W3033147043 modified "2023-09-25" @default.
• W3033147043 title "İnfantil hemanjiomların tedavisinde topikal beta-blokerlerin etkinliği" @default.
• W3033147043 cites W1598842294 @default.
• W3033147043 cites W1608484788 @default.
• W3033147043 cites W1813273257 @default.
• W3033147043 cites W1987326721 @default.
• W3033147043 cites W2041335901 @default.
• W3033147043 cites W2052640374 @default.
• W3033147043 cites W2064857592 @default.
• W3033147043 cites W2081699794 @default.
• W3033147043 cites W2087585527 @default.
• W3033147043 cites W2099565121 @default.
• W3033147043 cites W2105583681 @default.
• W3033147043 cites W2110591584 @default.
• W3033147043 cites W2143244595 @default.
• W3033147043 cites W2320277402 @default.
• W3033147043 cites W2328338930 @default.
• W3033147043 cites W2519546557 @default.
• W3033147043 doi "https://doi.org/10.31362/patd.684496" @default.
• W3033147043 hasPublicationYear "2020" @default.
• W3033147043 type Work @default.
• W3033147043 sameAs 3033147043 @default.
• W3033147043 citedByCount "0" @default.
• W3033147043 crossrefType "journal-article" @default.
• W3033147043 hasAuthorship W3033147043A5003503947 @default.
• W3033147043 hasAuthorship W3033147043A5009567221 @default.
• W3033147043 hasAuthorship W3033147043A5083712446 @default.
• W3033147043 hasAuthorship W3033147043A5086622209 @default.
• W3033147043 hasAuthorship W3033147043A5086849686 @default.
• W3033147043 hasBestOaLocation W30331470431 @default.
• W3033147043 hasConcept C29456083 @default.
• W3033147043 hasConcept C71924100 @default.
• W3033147043 hasConceptScore W3033147043C29456083 @default.
• W3033147043 hasConceptScore W3033147043C71924100 @default.
• W3033147043 hasLocation W30331470431 @default.
• W3033147043 hasLocation W30331470432 @default.
• W3033147043 hasOpenAccess W3033147043 @default.
• W3033147043 hasPrimaryLocation W30331470431 @default.
• W3033147043 hasRelatedWork W1506200166 @default.
• W3033147043 hasRelatedWork W1995515455 @default.
• W3033147043 hasRelatedWork W2039318446 @default.
• W3033147043 hasRelatedWork W2048182022 @default.
• W3033147043 hasRelatedWork W2080531066 @default.
• W3033147043 hasRelatedWork W2748952813 @default.
• W3033147043 hasRelatedWork W2899084033 @default.
• W3033147043 hasRelatedWork W3031052312 @default.
• W3033147043 hasRelatedWork W3032375762 @default.
• W3033147043 hasRelatedWork W3108674512 @default.
• W3033147043 isParatext "false" @default.
• W3033147043 isRetracted "false" @default.
• W3033147043 magId "3033147043" @default.
• W3033147043 workType "article" @default.